EuDx-MTB Detection Kit
Negotiable Min Order Quantity Unit
- Required Quantity
-
- Place of Origin
- South Korea
- Payment Terms
- Negotiable
- Production method
- Negotiable
- Shipping / Lead Time
- Negotiable / Negotiable
- Keyword
- mtb, real-time pcr, detection kit
- Category
- Clinical Analytical Instrument
EuDiPia Co., Ltd.
South Korea
- Verified Certificate
-
10
| Product name | EuDx-MTB Detection Kit | Certification | - |
|---|---|---|---|
| Category | Clinical Analytical Instrument | Ingredients | - |
| Keyword | mtb , real-time pcr , detection kit | Unit Size | - |
| Brand name | - | Unit Weigh | - |
| origin | South Korea | Stock | - |
| Supply type | - | HS code | - |
Product Information
EuDx-MTB Detection Kit
│ DESCRIPTION │
EuDx™-MTB detection kit is an in vitro diagnostic reagent for the qualitative detection of M. tuberculosis present in the sputum, urine, tissues and blood of humans as well as in cultured samples using real-time DNA amplification method.
This detection kit is a product based on the nested multiplex real-time PCR method which has high sensitivity and specificity; as such, it is easier to detect small amount of M. tuberculosis while eliminating the problem of false positives and false negatives that may occur in the assays targeting a single DNA using IS6110 and rpoB, the 2 genes that are specific to M. tuberculosis.
- Detection Technology: One-tube Nested Multiplex Real-time PCR
- Specimens: sputum, urine, tissues, blood, cultures
- Target Genes: IS6110 and rpoB (specific to M. tuberculosis)
- Analytical Sensitivity： 10-102 copies
│ FEATURES │
- High Performance (Sensitivity & Specificity)
• Fusion of sensitive PCR techniques (Real-time PCR + Nested PCR)
• Detection of 2 target genes (Multiplex PCR)
• Using the highly efficient enzyme - Prevention of Contamination
• 2 step PCR → One tube test
• Addition of UDG(Uracil-DNA glycosylase) - Good Stability
• Long shelf life: 1 year
│ CONTENTS │
- 2X qPCR Premix
- Reaction Mixture (Primer/Probe + Internal Control)
- DNA Extraction Solution (x 4 tubes)
- Positive Control DNA
- Nuclease Free Water
│ SPECIFICATION │
- Compatible Real-Time Thermal Cyclers: ABI 7500, 7500 Fast
- Size: 96 Test/Kit
- Product Info Attached File
B2B Trade
| Price (FOB) | Negotiable | transportation | - |
|---|---|---|---|
| MOQ | Negotiable | Leadtime | Negotiable |
| Payment Options | Negotiable | Shipping time | Negotiable |
- President
- Kim Insoo
- Address
- #506,Venture Research Center,194-41 Osongsaengmyeong 1-ro, Osong-eup, Chungweon-gun,Chungcheongbuk-do,363-951,korea
- Product Category
- Medical Devices
- Year Established
- 2012
- No. of Total Employees
- 1-50
- Company introduction
-
☞ EuDiPia has established the headquarters and a research institute at the business center in Sogang University with a motto of “Diagnostics for Utopia” in September, 2012, and acquired certificate as a venture company from the KOTEC in April, 2013 and in January, 2014 moved into OSONG Medical Innovation Foundation. In June, 2014 EuDiPia has acquired KGMP(Korea Good Manufacturing Practice).
☞ EuDiPia possesses technology named One-tube Nested Multiplex real-time PCR, and the first product using that technology is the EuDxTM-MTB(Mycobacterium tuberculosis). And that has 100 times higher sensitivity compare to threshold cycle value of conventional real-time PCR products.
☞ “EuDxTM-MTB detection” that was registered with trade mark in April, 2013, that a company in partnership, Solgent Co., Ltd. has been consigned for the production of it. After acquired approval from MFDS(Ministry of Food & Drug Safety) in June, 2014 via proceeding of clinical trial in Seoul Asan Hospital, it is scheduled to provide products to large scaled institutions including general hospitals, central laboratories, and Korean Institute of Tuberculosis etc. starting from July, 2014.
☞ Technologies and products to be developed in the future are in the field of respiratory infectious diseases first and then covering other infectious viruses like hepatitis and HPVs etc. . It is planned to make a fully automated POCT system that is with improved convenience for users and also accuracy.
☞ For entering to the market, local distributors are to be involved for Korean market. And in case of China, the joint corporation is planned to be established. In addition, it is scheduled to establish country-specific trade route for emerging markets in other foreign countries. Achieves sales amount of ten billion won within 5 years since the first product is launched.
- Main Product
Related Products
Covid 19 Detection
CRYSTE Multi purpose Centrifuge VARISPIN 4
CRYSTE Autoclave Autoclave PURISTER 60/80/100
CRYSTE Multi purpose Centrifuge VARISPIN 4A
COVID 19 IgM / IgG RAPID KIT
